< Arab Finance - News - Memphis targets EGP 50.1M profits in FY 2022/2023
Count Down to relaunch



Memphis targets EGP 50.1M profits in FY 2022/2023

Memphis targets EGP 50.1M profits in FY 2022/2023

Arab FinanceMemphis Pharmaceutical (MPCI) is expected to achieve a net profit after tax of EGP 50.075 million in fiscal year (FY) 2022/2023, up from recorded EGP 41.8 million in FY 2020/2021, according to the company's budget estimates filed to the Egyptian Exchange (EGX) on June 9th.

The company's FY 2022/2023 also targets operating revenues of EGP 670 million, up from EGP 518.11 million in FY 2020/2021.

It is worth noting that Memphis' net profit after tax amounted to EGP 20.997 million during the nine-month period ended March 31st, compared to EGP 25.373 million in the same period of FY 2020/2021.

Memphis is one of the oldest pharmaceutical and chemical companies in the Middle East and has been in the market since 1940.

 

 

Recommended Stocks

13 Jun 2022
Delta Sugar SUGR
Close
22.35
Change
-03.54
Hold

All rights reserved to Arab Finance 2020 ©

Back to top